A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/714 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2750649
The present invention is directed to methods of treating eye disease. In one embodiment, the method can comprise administering a bioconjugate to a subject to treat the eye disease, where the bioconjugate comprises a taxane covalently bonded to a cobalamin. Additionally, the bioconjugate can be dissolved in an aqueous solution prior to administration.
La présente invention porte sur un procédé de traitement d'une maladie oculaire. Dans un mode de réalisation, le procédé peut comprendre l'administration d'un bioconjugué à un sujet dans le but de traiter la maladie oculaire, le bioconjugué comprenant un taxane lié de manière covalente à une cobalamine. De plus, le bioconjugué peut être dissous dans une solution aqueuse avant l'administration.
Gebhard John R.
Patel Dinesh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Osiris Therapeutics Inc.
LandOfFree
Cobalamin taxane bioconjugates for treating eye disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cobalamin taxane bioconjugates for treating eye disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cobalamin taxane bioconjugates for treating eye disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1384672